Literature DB >> 20725750

Overexpression of apelin receptor (APJ/AGTRL1) on hepatic stellate cells and sinusoidal angiogenesis in human cirrhotic liver.

Hiroaki Yokomori1, Masaya Oda, Kazunori Yoshimura, Sanae Machida, Fumihiko Kaneko, Toshifumi Hibi.   

Abstract

BACKGROUND: The apelin receptor (APJ) is related to angiotensin-like-receptor 1 (AGTRL1). This study was designed to elucidate the in vivo localization and changes of APJ in cirrhotic liver, and the in vitro changes of APJ expression in cultured hepatic stellate cells (HSCs) and capillarized sinusoidal endothelial cells (SECs) activated by growth factors.
METHODS: In vivo studies used control liver samples, cirrhotic liver samples from patients with Child's A cirrhosis undergoing surgical resection (Child-A-LC), and cirrhotic liver samples from autopsied cases of decompensated Child's C cirrhosis (Child-C-LC). Immunohistochemical (IHC), Western blot, laser-capture microdissection (LCM) coupled with reverse transcription -polymerase chain reaction (RT-PCR), and immunoelectron microscopic (IEM) studies for APJ expression were conducted. In vitro examinations used commercial human HSCs and SECs. APJ expression was examined in cultured HSCs activated by growth factors and in capillarized SECs activated by angiogenic factors.
RESULTS: The IHC study of liver samples revealed only slight APJ expression in hepatic sinusoids in control liver tissue. In cirrhotic liver (Child-A-LC and Child-C-LC), APJ expression was evident mainly along the sinusoids and on portal fibroblasts in fibrotic septa. Western blot analysis of whole-liver homogenate and LCM-PCR of sinusoids revealed overexpression of APJ in Child-C-LC samples. The results of IEM studies showed that APJ expression was increased significantly on HSCs, but it was sparse on SECs in Child-C-LC tissue. In vitro examination revealed that APJ was overexpressed in cultured HSCs activated by platelet-derived growth factor-β.
CONCLUSIONS: Enhanced expression of APJ on HSCs in cirrhosis indicates markedly increased vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20725750     DOI: 10.1007/s00535-010-0296-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  27 in total

1.  Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo.

Authors:  Junji Ishida; Tatsuo Hashimoto; Yasumi Hashimoto; Shiro Nishiwaki; Taku Iguchi; Shuichi Harada; Takeshi Sugaya; Hitomi Matsuzaki; Rie Yamamoto; Naotaka Shiota; Hideki Okunishi; Minoru Kihara; Satoshi Umemura; Fumihiro Sugiyama; Ken-Ichi Yagami; Yoshitoshi Kasuya; Naoki Mochizuki; Akiyoshi Fukamizu
Journal:  J Biol Chem       Date:  2004-04-15       Impact factor: 5.157

2.  Opposing cardiovascular roles for the angiotensin and apelin signaling pathways.

Authors:  Euan Ashley; Hyung J Chun; Thomas Quertermous
Journal:  J Mol Cell Cardiol       Date:  2006-09-26       Impact factor: 5.000

Review 3.  Laser micromanipulation systems as universal tools in cellular and molecular biology and in medicine.

Authors:  K Schütze; H Pösl; G Lahr
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1998-07       Impact factor: 1.770

4.  Laser capture microdissection.

Authors:  M R Emmert-Buck; R F Bonner; P D Smith; R F Chuaqui; Z Zhuang; S R Goldstein; R A Weiss; L A Liotta
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

5.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.

Authors:  P Lindahl; B R Johansson; P Levéen; C Betsholtz
Journal:  Science       Date:  1997-07-11       Impact factor: 47.728

6.  A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11.

Authors:  B F O'Dowd; M Heiber; A Chan; H H Heng; L C Tsui; J L Kennedy; X Shi; A Petronis; S R George; T Nguyen
Journal:  Gene       Date:  1993-12-22       Impact factor: 3.688

7.  Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells.

Authors:  M Pinzani; L Gesualdo; G M Sabbah; H E Abboud
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

8.  Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.

Authors:  K Tatemoto; M Hosoya; Y Habata; R Fujii; T Kakegawa; M X Zou; Y Kawamata; S Fukusumi; S Hinuma; C Kitada; T Kurokawa; H Onda; M Fujino
Journal:  Biochem Biophys Res Commun       Date:  1998-10-20       Impact factor: 3.575

9.  Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.

Authors:  Ramón Bataller; Pau Sancho-Bru; Pere Ginès; José M Lora; Amal Al-Garawi; Manel Solé; Jordi Colmenero; Josep M Nicolás; Wladimiro Jiménez; Nadine Weich; José-Carlos Gutiérrez-Ramos; Vicente Arroyo; Juan Rodés
Journal:  Gastroenterology       Date:  2003-07       Impact factor: 22.682

10.  Caveolin-1 and Rac regulate endothelial capillary-like tubular formation and fenestral contraction in sinusoidal endothelial cells.

Authors:  Hiroaki Yokomori; Masaya Oda; Kazunori Yoshimura; Toshihiro Nagai; Kayo Fujimaki; Shuichi Watanabe; Toshifumi Hibi
Journal:  Liver Int       Date:  2008-12-02       Impact factor: 5.828

View more
  18 in total

Review 1.  Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery.

Authors:  Sanju Narayanan; Danni L Harris; Rangan Maitra; Scott P Runyon
Journal:  J Med Chem       Date:  2015-07-10       Impact factor: 7.446

2.  Apelin is a marker of the progression of liver fibrosis and portal hypertension in patients with biliary atresia.

Authors:  Wei Chen; Takaharu Oue; Takehisa Ueno; Shuichiro Uehara; Noriaki Usui; Masahiro Fukuzawa
Journal:  Pediatr Surg Int       Date:  2013-01       Impact factor: 1.827

3.  Protective effect of apelin preconditioning in a rat model of hepatic ischemia reperfusion injury; possible interaction between the apelin/APJ system, Ang II/AT1R system and eNOS.

Authors:  Maha M Sabry; Nagwa M Ramadan; Basant A Al Dreny; Laila A Rashed; Ayman Abo El Enein
Journal:  United European Gastroenterol J       Date:  2019-01-23       Impact factor: 4.623

4.  Chronic apelin treatment improves hepatic lipid metabolism in obese and insulin-resistant mice by an indirect mechanism.

Authors:  Chantal Bertrand; Jean-Philippe Pradère; Nancy Geoffre; Simon Deleruyelle; Bernard Masri; Jean Personnaz; Sophie Le Gonidec; Aurélie Batut; Katie Louche; Cédric Moro; Philippe Valet; Isabelle Castan-Laurell
Journal:  Endocrine       Date:  2018-02-01       Impact factor: 3.633

5.  Emerging role of adipokine apelin in hepatic remodelling and initiation of carcinogensis in chronic hepatitis C patients.

Authors:  Rola M Farid; Riham M Abu-Zeid; Ahmed El-Tawil
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

6.  Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells.

Authors:  Devaraj Ezhilarasan
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-13

7.  Identification of potent pyrazole based APELIN receptor (APJ) agonists.

Authors:  Sanju Narayanan; Vineetha Vasukuttan; Sudarshan Rajagopal; Rangan Maitra; Scott P Runyon
Journal:  Bioorg Med Chem       Date:  2019-11-30       Impact factor: 3.641

8.  Apelin serum level in Egyptian patients with chronic hepatitis C.

Authors:  Hala O El-Mesallamy; Nadia M Hamdy; Hanan H Rizk; Abdel-Rahman El-Zayadi
Journal:  Mediators Inflamm       Date:  2011-10-04       Impact factor: 4.711

9.  The Apelin-Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis.

Authors:  Lixian Chen; Tianhao Zhou; Tori White; April O'Brien; Sanjukta Chakraborty; Suthat Liangpunsakul; Zhihong Yang; Lindsey Kennedy; Romil Saxena; Chaodong Wu; Fanyin Meng; Qiaobing Huang; Heather Francis; Gianfranco Alpini; Shannon Glaser
Journal:  Hepatology       Date:  2021-05-22       Impact factor: 17.298

Review 10.  Apelin/APJ system: A key therapeutic target for liver disease.

Authors:  Shuang-Yu Lv; Binbin Cui; Wei-Dong Chen; Yan-Dong Wang
Journal:  Oncotarget       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.